D59.19
Other autoimmune hemolytic anemia
Clinical Classification Guidelines
Medical Intelligence & Overview
Other autoimmune hemolytic anemia is a condition in which the immune system mistakenly attacks and destroys red blood cells. This leads to a shortage of these vital cells, which are responsible for carrying oxygen throughout the body. As a result, individuals with this condition may experience symptoms related to anemia, such as fatigue and weakness. The condition falls under the broader category of hemolytic anemias and is classified specifically as D59.19 in the ICD-10 coding system.
Causes & Symptoms
Clinical Causes: Autoimmune disorders where the immune system targets red blood cells Secondary to other diseases such as lupus or certain infections Medications that may trigger immune reactions leading to red blood cell destruction Unknown factors in some cases, with no identifiable cause Genetic predisposition in rare instances
Key Symptoms: Fatigue and weakness Shortness of breath Pale or yellowish skin (jaundice) Rapid heart rate Dark-colored urine Dizziness or light-headedness Enlarged spleen or liver in some cases
Diagnostic & Treatment
Diagnosis Path: Diagnosing other autoimmune hemolytic anemia involves a combination of medical history, physical examination, and laboratory tests. Blood tests are crucial in identifying anemia and confirming the destruction of red blood cells. Specific tests include:
Treatment Protocols: Treatment aims to manage symptoms, suppress the immune response, and prevent further red blood cell destruction. Approaches may include:
Clinical Advice & FAQs
Billing Guidance
Is D59.19 a billable ICD-10 code?
Yes, D59.19 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D59.19?
Clinical documentation must specify the nature of Other autoimmune hemolytic anemia and any associated comorbidities for accurate reporting.
Cite this Clinical Reference